Back to Atlas
CTransientStandard research/education caution
CMP-0417
Endogenous / research
Peptide YY (PYY 1-36)
Satiety / Metabolic
May reduce appetite and modulate post-meal satiety physiology
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Gut hormone peptide
- Primary mechanism
- NPY-family Y receptor signaling; appetite and GI motility regulation
- Primary market use
- Obesity/satiety research
Pharmacology
- Molecular weight (Da)
- ~4,311
- Oral bioavailability
- N/A (peptide; not oral)
- Half-life
- Rapidly processed; minutes-range
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Human/Clinical physiology
- Clinical status
- Endogenous / research
- Value-for-money score
- 2 / 10
Reported protocol signal
No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Native PYY is rapidly converted by DPP-4 to PYY(3-36); not practical without formulation